Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer

Lung cancer growth is dependent on angiogenesis. In recent years, angiogenesis inhibitors have attracted more and more attention as potential lung cancer treatments. Current anti-angiogenic drugs targeting VEGF or receptor tyrosine kinases mainly inhibit tumor growth by reducing angiogenesis and blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yingying, Lin, Mengmeng, Wang, Shiyuan, Cao, Bo, Li, Chunyu, Li, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965887/
https://www.ncbi.nlm.nih.gov/pubmed/35372042
http://dx.doi.org/10.3389/fonc.2022.842960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965887/
https://www.ncbi.nlm.nih.gov/pubmed/35372042
http://dx.doi.org/10.3389/fonc.2022.842960

Ejemplares similares